ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.46
      1.21%
      US Tech 100
      17,018.80
      1.59%
      Dow Jones
      38,505.24
      0.69%
      Brent Oil
      87.535
      1.30%
      Bitcoin
      66,535.93
      -0.48%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. GeneDx Holdings Corporation (WGS)

      7. GeneDx Holdings Corporation (WGS) News

      WGS GeneDx Holdings Corporation

      11.95
      1.56 (15.01%)
      Last Updated: 15:27:06
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      GeneDx Holdings Corporation WGS NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      1.56 15.01% 11.95 15:27:06
      Open Price Low Price High Price Close Price Prev Close
      10.23 10.1825 12.57 10.39
      more quote information »

      Recent News

      Date Time Source Heading
      4/23/202408:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
      4/04/202416:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
      3/14/202408:30GLOBEGeneDx to Present Data at the 2024 American College of..
      3/05/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/26/202416:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
      2/23/202416:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/20/202416:28EDGAR2Form 8-K - Current report
      2/20/202416:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
      2/01/202416:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
      1/24/202416:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
      1/23/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202408:58EDGAR2Form 8-K - Current report
      1/08/202408:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
      1/04/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202321:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202321:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/05/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202308:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
      11/28/202316:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
      11/20/202316:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
      11/17/202316:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/03/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      10/30/202316:33EDGAR2Form 8-K - Current report
      10/30/202316:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
      10/23/202317:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/09/202316:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
      10/03/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/22/202316:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
      9/19/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/19/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/12/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/12/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/11/202308:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
      9/06/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202308:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
      8/21/202307:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
      8/08/202320:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
      8/08/202316:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/08/202316:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
      8/08/202316:13EDGAR2Form 8-K - Current report
      8/08/202316:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
      8/07/202308:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
      7/27/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/24/202317:04EDGAR2Form 8-K - Current report
      7/21/202321:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/19/202307:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..
      7/18/202316:05GLOBEGeneDx to Report Second Quarter 2023 Financial Results on..

      Your Recent History

      NASDAQ
      WGS
      GeneDx
      Delayed Upgrade Clock